Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 6
1981 10
1982 15
1983 20
1984 16
1985 28
1986 32
1987 34
1988 42
1989 30
1990 40
1991 45
1992 41
1993 71
1994 80
1995 98
1996 107
1997 115
1998 106
1999 130
2000 119
2001 113
2002 114
2003 117
2004 121
2005 113
2006 129
2007 117
2008 127
2009 112
2010 122
2011 114
2012 137
2013 160
2014 130
2015 115
2016 122
2017 97
2018 117
2019 91
2020 95
2021 72
2022 44
2023 32
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

3,437 results

Results by year

Filters applied: . Clear all
Page 1
Complement receptors.
Bianco C, Nussenzweig V. Bianco C, et al. Contemp Top Mol Immunol. 1977;6:145-76. doi: 10.1007/978-1-4684-2841-4_5. Contemp Top Mol Immunol. 1977. PMID: 396104 Review. No abstract available.
Structure and specificity of complement receptors.
Sim RB, Malhotra V, Day AJ, Erdei A. Sim RB, et al. Immunol Lett. 1987 Feb;14(3):183-90. doi: 10.1016/0165-2478(87)90099-x. Immunol Lett. 1987. PMID: 3552967 Review.
Complement and complement receptors.
Ross GD. Ross GD. Curr Opin Immunol. 1989 Oct;2(1):50-62. doi: 10.1016/0952-7915(89)90097-6. Curr Opin Immunol. 1989. PMID: 2692625 Review. No abstract available.
Complement receptors.
Holers VM. Holers VM. Year Immunol. 1989;4:231-40. Year Immunol. 1989. PMID: 2538973 Review. No abstract available.
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression.
Magrini E, Di Marco S, Mapelli SN, Perucchini C, Pasqualini F, Donato A, Guevara Lopez ML, Carriero R, Ponzetta A, Colombo P, Cananzi F, Supino D, Reis ES, Peano C, Inforzato A, Jaillon S, Doni A, Lambris JD, Mantovani A, Garlanda C. Magrini E, et al. Nat Cancer. 2021 Feb;2(2):218-232. doi: 10.1038/s43018-021-00173-0. Epub 2021 Feb 18. Nat Cancer. 2021. PMID: 34505065 Free PMC article.
3,437 results